Christopher Galletta

Corporate Controller, TRANSACT TECHNOLOGIES INC.

Companies

Trevi Therapeutics, Inc.Officer Apr 15, 2021 to now¹
TRANSACT TECHNOLOGIES INCCorporate Controller Mar 4, 2010 to Jan 4, 2012²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Trevi Therapeutics, Inc. TRVI26,095 shares³$311.2K at $11.93Dec 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 2, 2025Exercised options 4,225 shares at $0.51 of Trevi Therapeutics, Inc.³
Dec 13, 2024Exercised options 15,000 shares at $0.51 of Trevi Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTrevi Therapeutics, Inc., Officer
2
SEC EDGARTRANSACT TECHNOLOGIES INC, Corporate Controller
3
SEC EDGARTrevi Therapeutics, Inc. shares after the filing of Dec 2, 2025
4
SEC EDGARForm 4 filed Dec 17, 2024